Navigation Links
Saudi Arabia Pharmaceutical Market Sales at US$7B by 2018 Forecasts a New Research Available at MarketReportsOnline.com
Date:9/15/2013

Dallas, Texas (PRWEB) September 15, 2013

Pharmaceuticals products sales in Saudi Arabia are expected to surpass US$ 7 Billion by 2018 as compare to US$ 4 Billion 2012. Saudi Arabia is expected to emerge as one of the fastest growing markets in future. The country is one of the most developed and technologically advanced medical sectors in the GCC Region with modern equipment and amenities. Saudi Arabia Pharmaceutical Market Opportunity Analysis (http://www.marketreportsonline.com/270352.html) report gives comprehensive insights on following aspects related to pharmaceutical market: Market Overview, Drug Pricing system, Disease Prevalence, Market by segment: Generics, Branded & OTC, Favorable Market dynamics and Regulatory Framework.

Saudi Arabia Pharmaceutical market has recorded significant growth over the years owing to various factors like increasing ageing population mostly in the above 60 years bracket, changing demographics and rise in the incidence of lifestyle diseases, increased spending power, result driven government initiatives to promote the growth of indigenous pharmaceutical companies. Inspite of all the progress, the pharmaceutical market in the Saudi Arabia is still in an emerging phase, and the drug manufacturing is at a relatively nascent stage owing to many challenges, which need to be resolved.

Saudi Arabia relies substantially on imports of pharmaceutical products, primarily from Europe, to meet local demand as a result of insufficient domestic drug production and lack of indigenous research capabilities. Government is taking efforts to promote FDI in the pharmaceutical sector especially directed to help development of skills of local companies to manufacture patented medicines as well. Policies like free trade agreements have played a significant role in encouraging foreign investments. Increased penetration of the healthcare sector by insurance providers, price regulation guidelines to ensure uniformity in pricing and dedicated healthcare reforms, have further ensured growth of pharmaceutical market in recent years.

Table of Contents for the report Saudi Arabia Pharmaceutical Market Opportunity Analysis (http://www.marketreportsonline.com/270352-toc.html) include:

1. Saudi Arabia Pharmaceutical Market Overview
1.1 Current Market Overview
1.2 Drug Pricing System
1.3 Disease Prevalence

2. Pharmaceutical Market by Segment
2.1 Branded Drugs
2.2 Generic drugs
2.3 OTC

3. Favourable Market Dynamics
3.1 Largest Market in Middle East
3.2 Promotion of Domestic Pharmaceutical Industry
3.3 Well Established Regulatory Framework
3.4 Demand for OTC & Generics Drugs
3.5 Import Dependent Market
3.6 Challenges to be Resolved
3.7 Future Growth Avenues

4. Regulatory & Policy Framework
4.1 Drug Approval Process (Generics, Biologicals, Radipharmaceuticals &New Chemical Entity)
4.2 Monoclonal Antibodies and Related Products Quality Guideline
4.3 Law of Pharmaceutical Establishments and Preparations
4.4 Guidelines on Biosimilars
4.4.1 Insulin
4.4.2 Interferons
4.4.3 Erythropoietin
4.4.4 Granulocyte-Colony Stimulating Factor
4.4.5 Human Growth Hormone

5. Competitive Landscape
5.1 SPIMACO
5.2 Tabuk Pharmaceuticals
5.3 Jamjoom Pharma
5.4 Julphar (Gulf Pharmaceutical Industries)
5.5 GSK
5.6 Pfizer
5.7 Novartis
5.8 Astra

List of Tables
Table 1-1: Pricing History and Legal Background in Saudi Arabia
Table 1-2: Drug Pricing for Generics
Table 1-3: Drug Pricing for Fixed Combinations

List of Figures
Figure 1-1: Saudi Arabia Pharmaceutical Market (US$ Billion), 2012-2018
Figure 1-2: Saudi Arabia Pharmaceutical Market by Segment (US$ Billion), 2012-2018
Figure 1-3: Saudi Arabia Pharmaceutical Market by Segment (%), 2012 & 2018
Figure 1-4: Factors Driving Growth in Saudi Pharmaceuticals Market
Figure 1-5: Components of Drug Pricing System in Saudi Arabia
Figure 1-6: Burden of Communicable & Non Communicable Diseases in Saudi Arabia, 2012 & 2030
Figure 1-7: Leading Causes of Death in Saudi Arabia, 2011
Figure 2-1: Saudi Arabian Branded Drugs Market Value (US$ Billion), 2012-2018
Figure 2-2: Saudi Arabian Generics Drug Market Value (US$ Billion), 2012-2018
Figure 2-3: Saudi Arabian OTC Drug Market(US$ Billion), 2012-2018
Figure 3-1: Share of Saudi Arabia in GCC Pharmaceuticals Market, 2012
Figure 3-2: Government Expenditure on Health as a % of Total Health Expenditure, 2011
Figure 3-3: Expenditure on Health as a % of Total Government Expenditure, 2011
Figure 4-1: Saudi Arabia Drug Approval Process

Explore more reports on the Pharmaceuticals market at http://www.marketreportsonline.com/cat/pharmaceuticals-market-research.html .

Other new reports by the same publisher available:

China Industrial Robots Market Opportunity Analysis research report is available at http://www.marketreportsonline.com/270350.html .

India Renewable Energy Sector Opportunity Analysis research report is available at http://www.marketreportsonline.com/270351.html .

Australia Solar Power Sector Opportunity Analysis research report is available at http://www.marketreportsonline.com/270353.html .

About Us:
MarketReportsOnline.com is an online database of regional industry research reports (http://www.marketreportsonline.com/latestreport.php) , company profiles and SWOT analysis studies for multiple industries, organizations and market segments. Our sales and research experts offer 24 X 7 support to our customers through phone and email communication. Not limited to the pharmaceuticals industry, MarketReportsOnline.com offers research studies on agriculture, banking and financial services, chemicals, energy, power, environment, food and beverages, healthcare, medical devices and much more.

Read the full story at http://www.prweb.com/releases/saudi-arabia-2018-report/pharmaceutical-market/prweb11121173.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Dissertation Help Launched in Saudi Arabia, UAE and other Middle Eastern Countries
2. Pacific Prime Clients with Aetna Gain New Medical Insurance Options in Saudi Arabia
3. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
4. MSU invention could help pharmaceutical industry save money
5. Nobel laureate to keynote international pharmaceutical conference at URI
6. 5 more pharmaceutical companies join NIH initiative to speed therapeutic discovery
7. Is it constitutional for states to regulate pharmaceutical gifts and meals to doctors?
8. Pharmica Consulting to Hold HIT Conference for the Pharmaceutical Industry
9. Scientists use sound waves to levitate liquids, improve pharmaceuticals
10. Medical care presents update on pharmaceutical health services research
11. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The American ... to become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer ... Elect beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. ...
(Date:10/13/2017)... ... ... Apple Rehab Shelton Lakes , which specializes in the delivery of sub-acute ... of a disaster drill on October 3rd. , Apple Rehab participated with the Shelton ... well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). The LTC-MAP ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and ... explains one of the most popular and least understood books in the Holy Scriptures, ... puzzling descriptions that have baffled scholars for centuries. Many have tossed it off as ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of ... Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, ... In honor of Morris F. Collen, a pioneer in the field of medical informatics, ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... 11, 2017  Caris Life Sciences ® , a ... promise of precision medicine, today announced that St. Jude ... Oncology Alliance™ (POA) as its 17 th member. ... Jude Crosson Cancer Institute will help develop standards of ... tumor profiling, making cancer treatment more precise and effective. ...
(Date:10/10/2017)... Oct. 10, 2017  NDS received FDA 510(k) clearance in May ... battery-powered display stand specifically designed for endoscopy environments. An innovative secondary ... a clinical solution to support the improvement of patient outcomes, procedural ... ... ...
(Date:10/5/2017)... , Oct. 5, 2017  In response to ... Oral and Maxillofacial Surgeons (AAOMS) released prescribing recommendations ... to be used as a first-line therapy to ... Recognizing the value ... White Paper "Opioid Prescribing: Acute and Postoperative Pain ...
Breaking Medicine Technology: